Expression of the chemokine IP‐10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation
暂无分享,去创建一个
Rakesh K. Kumar | G. Marinos | A. Lloyd | J. Post | R. Ffrench | A. Freeman | P. Palladinetti | Charles E. Harvey
[1] M. Law,et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. , 2003, Journal of hepatology.
[2] P. Manow. ‚The Good, the Bad, and the Ugly‘ , 2002 .
[3] A. Khoruts,et al. Visualizing the generation of memory CD4 T cells in the whole body , 2001, Nature.
[4] L. Lefrançois,et al. Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.
[5] T. Okanoue,et al. Increase of chemokine interferon‐inducible protein‐10 (IP‐10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes , 2001, Clinical and experimental immunology.
[6] M. Serio,et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.
[7] O. Kutsch,et al. Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes , 2000, Journal of Virology.
[8] M. Burdick,et al. The ratio of ELR+ to ELR− CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat , 2000, Hepatology.
[9] E. Brunt,et al. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond , 2000, Hepatology.
[10] D. Adams,et al. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. , 1999, Journal of immunology.
[11] R. Strieter,et al. The role of chemokines in the immunopathology of pulmonary disease. , 1999, Forum.
[12] C. O’Farrelly,et al. Prometheus through the looking glass: reflections on the hepatic immune system. , 1999, Immunology today (Amsterdam. Regular ed.).
[13] C. Mackay,et al. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.
[14] V. Agnello,et al. Detection of widespread hepatocyte infection in chronic hepatitis C , 1998, Hepatology.
[15] J. Flier,et al. Chemokine IP-10 expression in cultured human keratinocytes , 1998, Archives of Dermatological Research.
[16] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[17] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[18] S. Hübscher. Histological grading and staging in chronic hepatitis: clinical applications and problems. , 1998, Journal of hepatology.
[19] M. Koziel. The role of immune responses in the pathogenesis of hepatitis C virus infection , 1997, Journal of viral hepatitis.
[20] M. Shin,et al. Induction of IP-10 chemokine promoter by measles virus: comparison with interferon-γ shows the use of the same response element but with differential DNA–protein binding profiles , 1997, Journal of Neuroimmunology.
[21] Y. Tominaga,et al. Expression of IFN-inducible protein-10 in chronic hepatitis. , 1997, Journal of immunology.
[22] O. Schiraldi,et al. In‐situ immunophenotyping study of hepatic‐infiltrating cytotoxic cells in chronic active hepatitis C , 1997, European journal of gastroenterology & hepatology.
[23] D. Adams,et al. Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.
[24] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[25] V. Paradis,et al. Histological features predictive of liver fibrosis in chronic hepatitis C infection. , 1996, Journal of clinical pathology.
[26] A. Sher,et al. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. , 1996, Journal of immunology.
[27] R. Purcell,et al. Hepatitis C virus-associated fulminant hepatic failure. , 1996, The New England journal of medicine.
[28] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[29] T. Standiford,et al. "The good, the bad, and the ugly." The role of chemokines in models of human disease. , 1996, Journal of immunology.
[30] C. Chu,et al. T‐cell–mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection , 1995, Hepatology.
[31] D. Taub,et al. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. , 1995, Journal of immunology.
[32] P. Leder,et al. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.
[33] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[34] J. Ludwig,et al. Liver biopsy features of acute hepatitis C compared with hepatitis A, B, and non-A, non-B, non-C. , 2008, Liver.
[35] D. Taub,et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.
[36] S. Gaiani,et al. Persistent hepatitis C viraemia without liver disease , 1993, The Lancet.
[37] E. Schiff,et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. , 1993, Gastroenterology.
[38] F. Schaffner,et al. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis , 1992, Hepatology.
[39] P. Scheuer,et al. Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.
[40] R. Purcell,et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.
[41] R. K. Kumar,et al. Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica. , 1989, The American journal of pathology.
[42] K. Weinbren. The pathology of hepatitis. , 1952, The Journal of pathology and bacteriology.